{
  "compound": "THC, nabiximols, dronabinol",
  "condition": "TOURETTE_SYNDROME",
  "effect_size": "Large (SMD = 0.82)",
  "study_type": "SYSTEMATIC_REVIEW",
  "source": "NORML:TS_SYSTEMATIC_REVIEW_001",
  "participants": "8 studies (N=190 patients)",
  "year": 2020,
  "notes": "Cannabinoids for Tourette Syndrome: Systematic Review and Meta-Analysis",
  "confidence": "medium",
  "abstract": "Pooled SMD = -0.82 (95% CI: -1.21 to -0.43, p<0.001); Large effect size; Consistent benefit across studies"
}